P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States.
$4.00+4.71%
报价 2026-11-06
市值
$13.1M
EV
$82.4M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -75.7%
$1.52$16.47
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
L2 2026-05-21全文 ↓尚未生成 L3 估值，没有三情景目标价。去生成估值 →
基本面判断
›注意
TTM PE/EV/EBITDA 为负,仅 P/S 具参考意义;历史均值因数据缺失无法列示。
历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| PIIIP3 Health Partners Inc. | $13.1M | +4.7% | +7.8% | 50.6% | – | – | – | |
| TLPHTalphera, Inc. | $54.5M | +4.0% | +29430.6% | -4,075% | – | – | – | |
| IBIOiBio, Inc. | $47.5M | +1.2% | -50.0% | -160% | – | – | – | |
| HYPDHyperion DeFi, Inc. | $37.7M | -2.7% | +780.0% | 78.4% | – | – | – | |
| TAOXTAO Synergies Inc. | $20.4M | +8.3% | – | 99.9% | – | – | – | |
| BMGLBasel Medical Group Ltd Ordinary Shares | $8.4M | +1.9% | – | -2.4% | – | – | – | |
| INTSIntensity Therapeutics, Inc. | $8.1M | -3.2% | – | 0% | – | – | – | |
| 同行中位数 | – | – | +780.0% | -1.2% | – | – | – |
研究全文
财务报表
暂无季度数据（首次研究运行后填充）。
研究材料
Filing 摘要